Pharma Aids Limited (DSE:PHARMAID)
Bangladesh · Delayed Price · Currency is BDT 505.60
-7.20 (-1.40%)
At close: Nov 12, 2026
Pharma Aids Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | 87.52 | 63.82 | 61.19 | -6.38 | 34.76 |
Depreciation & Amortization | 10.68 | 6.5 | 6.92 | 7.62 | 7.82 |
Loss (Gain) From Sale of Assets | 0.01 | - | - | - | - |
Other Operating Activities | -6.74 | -4.9 | -4.82 | -6.51 | -3.69 |
Change in Accounts Receivable | 19.04 | -30.73 | 1.63 | -2.54 | 6.21 |
Change in Inventory | -22 | 10.81 | -17.47 | 6.5 | -15.18 |
Change in Accounts Payable | 2.3 | -1.67 | 3.89 | 0.24 | 1.25 |
Change in Other Net Operating Assets | -14.15 | -4.07 | -28.55 | 8.33 | 2.67 |
Operating Cash Flow | 76.64 | 39.76 | 22.79 | 7.27 | 33.85 |
Operating Cash Flow Growth | 92.77% | 74.49% | 213.55% | -78.53% | 7.77% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -20.44 | -57.13 | -0.18 | -2.21 | -4.7 |
Sale of Property, Plant & Equipment | 0.02 | 0.55 | - | - | - |
Sale (Purchase) of Real Estate | - | -13.53 | - | - | - |
Other Investing Activities | 0.05 | - | 0.11 | 0.2 | 0.37 |
Investing Cash Flow | -20.37 | -70.12 | -0.07 | -2.01 | -4.33 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | - | 16.49 | - | 0.49 | 0.68 |
Total Debt Issued | - | 16.49 | - | 0.49 | 0.68 |
Short-Term Debt Repaid | - | - | -0.28 | - | - |
Total Debt Repaid | - | - | -0.28 | - | - |
Net Debt Issued (Repaid) | - | 16.49 | -0.28 | 0.49 | 0.68 |
Common Dividends Paid | -9.69 | -7.66 | -4.83 | -15.54 | -25.27 |
Financing Cash Flow | -9.69 | 8.83 | -5.11 | -15.05 | -24.59 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | 0 | - |
Net Cash Flow | 46.59 | -21.53 | 17.61 | -9.79 | 4.93 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 56.2 | -17.37 | 22.6 | 5.06 | 29.15 |
Free Cash Flow Growth | - | - | 346.82% | -82.64% | 37.97% |
Free Cash Flow Margin | 11.08% | -3.97% | 5.37% | 1.64% | 9.02% |
Free Cash Flow Per Share | 18.01 | -5.57 | 7.25 | 1.62 | 9.34 |
Levered Free Cash Flow | 179.07 | -88.26 | 5.59 | 9.86 | 20.13 |
Unlevered Free Cash Flow | 180.64 | -87.17 | 5.75 | 10.01 | 20.37 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | - | 1.75 | 0.26 | 0.24 | 0.24 |
Cash Income Tax Paid | - | 27.15 | 32.43 | 23.71 | 25.15 |
Change in Working Capital | -14.81 | -25.66 | -40.5 | 12.54 | -5.05 |